Associate Professor of Medicine, Brigham and Women's Hospital
Cardiology
Dr. Michael M. Givertz, MD
|
|
Give Review
Michael M. Givertz is an expert in the field of Cardiology. He went to Harvard Medical School. Harvard Medical School is a one of the best medicals schools. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He has 1 awards "Fellow (FACC)". Michael Givertz has written publications. He has 63 publications published with PubMed. The lastest paper is: 'Variable Contribution of Heart Failure toQuality of Life in Ambulatory Heart Failure With Reduced, Better, or Preserved Ejection Fraction.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- MicroRNAs relate to early worsening of renal function in patients with acute Heart failure.
- Plasma kidney injury molecule-1 in Heart failure: renal mechanisms and clinical outcome.
- Left ventricular dimension decrement index early after axial flow assist device implantation: A novel risk marker for late pump thrombosis.
- Early management of patients with acute Heart failure: state of the art and future directions. A consensus document from the society for academic emergency medicine/he...
- What is Old is Now New: Insights into Cardiorenal Physiology.
- Relation of Serum Uric Acid Levels and Outcomes Among Patients Hospitalized for Worsening Heart Failure With Reduced Ejection Fraction (from the Efficacy of Vasopressi...
- Response to Sexton: inhibiting the Renin-Angiotensin-aldosterone system in patients with Heart failure and renal dysfunction: common sense or nonsense?
- International differences in clinical characteristics, management, and outcomes in acute Heart failure patients: better short-term outcomes in patients enrolled in Eas...
- Assessment and management of Heart failure after left ventricular assist device implantation.
- Impact of pre-diabetes on Heart transplant outcomes in patients with advanced Heart failure.
- Assessment of Myocardial viability and left ventricular function in patients supported by a left ventricular assist device.
- Quantifying the effect of cardiorenal Syndrome on mortality after left ventricular assist device implant.
- Low-Dose Dopamine or Low-Dose Nesiritide in Acute Heart Failure With Renal Dysfunction: The ROSE Acute Heart Failure Randomized Trial.
- Discharge Outcomes in Patients With Paracorporeal Biventricular Assist Devices.
- The challenge of drug development in acute Heart failure: balancing mechanisms, targeting patients, and gambling on outcomes.
- Incidence and risk factors for herpes zoster following Heart transplantation.
- Cardiac allograft involvement by post-transplantation lymphoproliferative disorder.
- Epidemiology and Natural History of Recovery of Left Ventricular Function in Recent Onset Dilated Cardiomyopathies.
- Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in Heart failure with preserved ejection fraction: a randomized clinical trial.
- Giant left ventricular Aneurysm as a late complication of inferior myocardial infarction.
- VEGF-C, VEGF-A and related angiogenesis factors as biomarkers of allograft vasculopathy in cardiac transplant recipients.
- Multimodality imaging of an adult with Shone complex.
- Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute Heart failure: An analysis from Diuretic Optimization Stra...
- Pediatric Heart failure and worsening renal function: Association with outcomes after Heart transplantation.
- Early vitamin C and E supplementation and cardiac allograft vasculopathy: 10-Year follow-up from a randomized, controlled study.
- Ventricular assist devices: important information for patients and families.
- Impact of serial troponin release on outcomes in patients with acute Heart failure: analysis from the PROTECT pilot study.
- Hemodynamic monitoring to guide treatment of acute Heart failure.
- Heart failure with recovered ejection fraction: a distinct clinical entity.
- Novel Biomarkers in Acute Heart Failure.
- Case report: exercise in a patient with acute decompensated Heart failure receiving positive inotropic therapy.
- Effects of the Adenosine A(1) Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction Results From PROTECT (Placeb...
- Functionally competent cardiac stem cells can be isolated from endoMyocardial biopsies of patients with advanced cardiomyopathies.
- Early dyspnoea relief in acute Heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study.
- Improved survival in Heart transplant recipients in the United States: racial differences in era effect.
- Cardiac magnetic resonance aids in the diagnosis of mitochondrial Cardiomyopathy.
- The effects of adenosine A(1) receptor antagonism in patients with acute decompensated Heart failure and worsening renal function: the REACH UP study.
- Dilated cardiomyopathy with conduction Disease and arrhythmia.
- Socioeconomic position, ethnicity, and outcomes in Heart transplant recipients.
- Right ventricular dysfunction during intensive pharmacologic unloading persists after mechanical unloading.
- The effect of renin-angiotensin system inhibitors on mortality and Heart failure hospitalization in patients with Heart failure and preserved ejection fraction: a syst...
- Multimodality imaging of right Atrial masses.
- Patient expectations from implantable defibrillators to prevent death in Heart failure.
- Clinical predictors of hepatic fibrosis in chronic advanced Heart failure.
- Adenosine A1 receptor antagonists at a fork in the road.
- Ventricular assist devices the challenges of outpatient management.
- Managing acute renal failure in patients with acute decompensated Heart failure: the cardiorenal syndrome.
- Evaluation for a ventricular assist device: selecting the appropriate candidate.
- Handheld echocardiography offers rapid assessment of clinical volume status.
- The association between high-dose diuretics and clinical stability in ambulatory chronic Heart failure patients.
- Direct Myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships.
- Epicardial left ventricular lead placement for cardiac resynchronization therapy following failed Coronary sinus approach.
- Heart failure and diabetes: collateral benefit of chronic disease management.
- B-type natriuretic peptide and the stressed Heart.
- Characteristics of patients who die with Heart failure and a low ejection fraction in the new millennium.
- Modulation of myocardial energetics: emerging evidence for a therapeutic target in cardiovascular Disease.
- Intensity and focus of Heart failure disease management after hospital discharge.
- Frequency and impact of delayed decisions regarding Heart transplantation on long-term outcomes in patients with advanced Heart failure.
- Endothelin mediates increased pulmonary vascular tone in patients with Heart failure: demonstration by direct intrapulmonary infusion of sitaxsentan.
- Exhaled nitric oxide: a marker of pulmonary hemodynamics in Heart failure.
- Variable Contribution of Heart Failure to Quality of Life in Ambulatory Heart Failure With Reduced, Better, or Preserved Ejection Fraction.
- Procalcitonin-based indication of bacterial infection identifies high risk acute Heart failure patients.
Schools
Harvard Medical School
Brigham and Women39s Hospital Ma
Brigham and Women39s Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Medicare Advantage PFFS
- Humana
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- Universal American
Awards
- Fellow (FACC)
Education
-
Brigham and Women's Hospital -
Harvard Medical School
Hospital
-
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1265499560 | |
| NPPES Provider LastName | GIVERTZ | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 024456002 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 368.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1265499560 |
| Last Name Of The Provider | GIVERTZ |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Andrew N. Rassi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allon Rafael, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony J. Choi, MD |
|
|
Dr. Andrew M. Bellinger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine M. Albert, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Neil J. Wimmer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vikas Veeranna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick T. Ogara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter G. Sanchez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael O. Sweeney, MD |
|
|
Dr. Annabel Chen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian C. Downey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Flora Sam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aalap Chokshi, MD
This Doctor is OpenDoctor Recommended.
|